Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module | 
| 3760779017 | Carmellose- and hydroxyapatite-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 3760780019 | Product containing carmellose and hydroxyapatite in parenteral dose form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 3760781015 | Carboxymethylcellulose- and hydroxyapatite-containing product in parenteral dose form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 4042418019 | Product containing carmellose and durapatite in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 4042419010 | Carboxymethylcellulose- and durapatite-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core | 
| 4377881000052115 | läkemedel som innehåller karboximetylcellulosa och hydroxiapatit i parenteral läkemedelsform | sv | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) | 
| 4516971000052116 | läkemedel som innehåller hydroxiapatit och karboximetylcellulosa, parenteral läkemedelsform | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) | 
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Carmellose- and hydroxyapatite-containing product in parenteral dose form | Is a | Carmellose- and hydroxyapatite-containing product | true | Inferred relationship | Some | ||
| Carmellose- and hydroxyapatite-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Carmellose- and hydroxyapatite-containing product in parenteral dose form | Is a | Hydroxyapatite-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Carmellose- and hydroxyapatite-containing product in parenteral dose form | Has active ingredient | Carmellose | true | Inferred relationship | Some | 1 | |
| Carmellose- and hydroxyapatite-containing product in parenteral dose form | Has active ingredient | hydroxiapatit | false | Inferred relationship | Some | 2 | |
| Carmellose- and hydroxyapatite-containing product in parenteral dose form | Has active ingredient | Durapatite (substance) | true | Inferred relationship | Some | 2 | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Carmellose and hydroxyapatite only product in parenteral dose form | Is a | True | Carmellose- and hydroxyapatite-containing product in parenteral dose form | Inferred relationship | Some | 
This concept is not in any reference sets